ODDB.org: Open Drug Database

Future Health Pharma GmbH - abnobaVISCUM Fraxini 2 mg, anthroposophisches Arzneimittel

Swissmedic Registration	68315	Sequence	02
Product name	abnobaVISCUM Fraxini 2 mg	Description	anthroposophisches Arzneimittel
ATC-Classification	L01CX	ATC-Description	Other Plant Alkaloids and Natural Products
Introduction of Sequence	28.10.2022

Composition

visci albi fraxini herbae recentis extractum liquidum (viscum album ssp. album L., herba; Wirtsbaum: Fraxinus excelsior L., Fraxinus angustifolia Vahl oder ihre Hybriden) 0.1 ml, DER: 1:50 Auszugsmittel dinatrii phosphas dihydricus et acidum ascorbicum et aqua ad iniectabile (2.03: 0.34: 97,63), dinatrii phosphas dihydricus, acidum ascorbicum, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 5.4 mg.

Packungsbestandteile

Galenic Form

anthroposophisches Arzneimittel

Excipiens

Active Agent	Dose
Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden)	0.1 ml

Inactive agents
Ascorbic Acid
Auszugsmittel Dinatrii Phosphas Dihydricus et Acidum Ascorbicum et aqua ad Iniectabile (2.03: 0.34: 97,63)
Der: 1:50
Disodium Phosphate Dihydrate

Package number	Package Size	EFP	CP	Category	Out of trade (MedRef)
011	8 x 1 ml	PR	PR	A	Yes
012	21 x 1 ml	PR	PR	A	Yes
013	48 x 1 ml	PR	PR	A	Yes

2024	©ywesee GmbH